CA2927334C - Water soluble pharmaceutical film with enhanced stability - Google Patents

Water soluble pharmaceutical film with enhanced stability Download PDF

Info

Publication number
CA2927334C
CA2927334C CA2927334A CA2927334A CA2927334C CA 2927334 C CA2927334 C CA 2927334C CA 2927334 A CA2927334 A CA 2927334A CA 2927334 A CA2927334 A CA 2927334A CA 2927334 C CA2927334 C CA 2927334C
Authority
CA
Canada
Prior art keywords
film
moisture
drying
range
water soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2927334A
Other languages
English (en)
French (fr)
Other versions
CA2927334A1 (en
Inventor
Anwar Siraj DAUD
Nidhi Prakash SAPKAL
Minal Nandkumar BONDE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ZIM Laboratories Ltd
Original Assignee
ZIM Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ZIM Laboratories Ltd filed Critical ZIM Laboratories Ltd
Publication of CA2927334A1 publication Critical patent/CA2927334A1/en
Application granted granted Critical
Publication of CA2927334C publication Critical patent/CA2927334C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
CA2927334A 2013-10-14 2014-10-13 Water soluble pharmaceutical film with enhanced stability Active CA2927334C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN3221/MUM/2013 2013-10-14
PCT/IN2014/000652 WO2015083181A2 (en) 2013-10-14 2014-10-13 Water soluble pharmaceutical film with enhanced stability
IN3221MU2013 IN2013MU03221A (https=) 2013-10-14 2014-10-13

Publications (2)

Publication Number Publication Date
CA2927334A1 CA2927334A1 (en) 2015-06-11
CA2927334C true CA2927334C (en) 2023-08-29

Family

ID=53274239

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2927334A Active CA2927334C (en) 2013-10-14 2014-10-13 Water soluble pharmaceutical film with enhanced stability

Country Status (8)

Country Link
BR (1) BR112016008356B1 (https=)
CA (1) CA2927334C (https=)
CL (1) CL2016000880A1 (https=)
EA (1) EA038558B1 (https=)
IN (1) IN2013MU03221A (https=)
MY (1) MY184297A (https=)
UA (1) UA123893C2 (https=)
WO (1) WO2015083181A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015107544A2 (en) * 2013-12-17 2015-07-23 Zim Laboratories Limited Pharmaceutical microemulsion immobilized in a thin polymer matrix and methods of making them
EP3600265A1 (en) * 2017-03-30 2020-02-05 Intelgenx Corp. Method of treatment and device for the improved bioavailability of leukotriene receptor antagonists
DE102017127452A1 (de) * 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag Wasserlösliche Polymerklebschichten
FR3082851B1 (fr) * 2018-06-25 2022-09-02 Biomerieux Sa Procede de detection et/ou d'identification d'au moins un microorganisme cible present sur une surface.
CN119015263B (zh) * 2024-08-20 2025-07-11 云南白药集团无锡药业有限公司 一种云南白药口溶膜剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5947987B2 (ja) * 1979-10-08 1984-11-22 富士写真フイルム株式会社 加筆・修正可能なマツトフイルム
US4664859A (en) * 1983-12-02 1987-05-12 Vcf Films Inc. Div. Of Pmc Process for solvent casting a film
US5272191A (en) * 1991-08-21 1993-12-21 Fmc Corporation Cold water soluble films and film forming compositions
US6966960B2 (en) * 2003-05-07 2005-11-22 Hewlett-Packard Development Company, L.P. Fusible water-soluble films for fabricating three-dimensional objects
WO2005084636A2 (en) * 2004-02-27 2005-09-15 Ranbaxy Laboratories Limited A process for the preparation of controlled-release pharmaceutical composition of metoprolol
KR100705210B1 (ko) * 2004-09-23 2007-04-06 주식회사 한독약품 경구투여를 위한 당뇨병 치료용 약제학적 복합제제
US20090162516A1 (en) * 2007-12-21 2009-06-25 Brown Solomon E Edible, water-soluble film

Also Published As

Publication number Publication date
IN2013MU03221A (https=) 2015-07-03
BR112016008356A2 (pt) 2017-08-01
WO2015083181A3 (en) 2015-12-03
BR112016008356B1 (pt) 2022-12-13
EA201690751A1 (ru) 2016-08-31
CA2927334A1 (en) 2015-06-11
WO2015083181A2 (en) 2015-06-11
EA038558B1 (ru) 2021-09-14
CL2016000880A1 (es) 2017-01-27
MY184297A (en) 2021-03-31
UA123893C2 (uk) 2021-06-23

Similar Documents

Publication Publication Date Title
CA2927334C (en) Water soluble pharmaceutical film with enhanced stability
US20090253754A1 (en) Fast dissolving films and coatings for controlled release of flavors, active pharmaceutical ingredients, food substances, and nicotine
US20120244197A1 (en) Film-Like Pharmaceutical Dosage Forms
JP7347474B2 (ja) 経口フィルム製剤
WO2019013260A1 (ja) 腸溶性硬質カプセル
JP6304234B2 (ja) コーティング組成物、コーティング製剤及びその製造方法
CN101316579A (zh) 含有抗粘组合物的用于快速溶解剂型的均匀膜
CA2794309A1 (en) Layered drug delivery device
JP2010519325A (ja) 活性物質の経口投与のための速崩壊性単層膜
TW201813633A (zh) 包衣組成物和包衣製劑及其製造方法
Arora et al. A review on new generation orodispersible films and its novel approaches
US20210253291A1 (en) Orodispersible films having quick dissolution times for therapeutic and food use
EP3811976B1 (en) Enteric hard capsule
CN103079596B (zh) 药物固体制剂用的包衣剂、药物用膜制剂以及包覆药物固体制剂
CN104884041B (zh) 用于治疗和食品用途的具有快速溶解时间的口服分散膜
US8900628B2 (en) Hard capsule and method for producing same
TW201909888A (zh) 包衣組成物、包衣膜、包衣製劑及其製造方法
CN109862884A (zh) 包含无定形索非布韦的固体药物组合物
JP5991978B2 (ja) カンデサルタンシレキセチル含有医薬組成物
CN115397397A (zh) 醋酸乌利司他otf
Almurisi et al. Development and In Vitro Evaluation of Aceclofenac Buccal Film
WO2012120366A1 (en) Novel moisture barrier immediate release film coating composition
WO2009055923A1 (en) Ingestible film composition
Akin et al. Formulation and In vitro Evaluation of a Fast-dissolving Oral Film of Triamcinolone Acetonide for Recurrent Aphthous Stomatitis
EP4489725A1 (en) Transmucosal therapeutic system containing a macrolide immunosuppressant

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20191011

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 10TH ANNIV.) - STANDARD

Year of fee payment: 10

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20240923

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20240923

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20240923

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 11TH ANNIV.) - STANDARD

Year of fee payment: 11

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250922

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250922